Stay up to date on the latest science with Brush Up Summaries. What Are Peripheral Blood Mononuclear Cells? Human peripheral blood mononuclear cells (PBMCs) are immune cells in the peripheral blood ...

Arvinas' ARV-102 reduced LRRK2 protein in a Phase 1 trial, showing promising safety and pharmacodynamic outcomes for ...

The World Health Organization recognises the test as the “only” enzyme-linked immunospot-based interferon-gamma release assay ...

BioIVT provides isolated peripheral blood mononuclear cells (PBMCs) from normal donors, which can be delivered fresh within 24 hours to specific locations or cryopreserved with demographic ...

Patients with systemic sclerosis and calcinosis cutis may have a higher tendency for bone-resorbing cell activity, suggesting ...

A first-in-human trial of Arvinas’ investigational Parkinson’s’ disease therapy, ARV-102, has been able to demonstrate a drop in the multifunctional protein that has been associated with the disease ...

The following is a summary of “Recall vaccination increases detectable B-cell reactivity in persons with multiple sclerosis treated with ocrelizumab,” published in the April 2025 issue of Journal of ...

“We look forward to demonstrating the same protective effect in cells collected from CKD patients, which will be an excellent surrogate of future efficacy of Gemini in our target indications.